West Pharmaceutical Services Inc. (WST) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC grew its holdings in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 9.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,609 shares of the medical instruments supplier’s stock after buying an additional 499 shares during the period. Janney Montgomery Scott LLC’s holdings in West Pharmaceutical Services were worth $618,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of WST. Vanguard Group Inc increased its stake in shares of West Pharmaceutical Services by 2.0% during the third quarter. Vanguard Group Inc now owns 7,067,729 shares of the medical instruments supplier’s stock valued at $872,652,000 after buying an additional 139,098 shares during the period. Virtu Financial LLC purchased a new position in shares of West Pharmaceutical Services during the fourth quarter valued at approximately $239,000. Fisher Asset Management LLC increased its stake in shares of West Pharmaceutical Services by 0.3% during the fourth quarter. Fisher Asset Management LLC now owns 924,964 shares of the medical instruments supplier’s stock valued at $90,674,000 after buying an additional 2,463 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of West Pharmaceutical Services by 8.4% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,074 shares of the medical instruments supplier’s stock valued at $497,000 after buying an additional 394 shares during the period. Finally, Arizona State Retirement System increased its stake in shares of West Pharmaceutical Services by 1.8% during the fourth quarter. Arizona State Retirement System now owns 53,170 shares of the medical instruments supplier’s stock valued at $5,212,000 after buying an additional 954 shares during the period. 92.56% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms have recently issued reports on WST. William Blair began coverage on West Pharmaceutical Services in a research note on Tuesday, April 23rd. They set an “outperform” rating and a $112.16 target price on the stock. Jefferies Financial Group cut West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 price target on the stock. in a research note on Wednesday, May 1st. Finally, Zacks Investment Research raised West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd.

In related news, VP Daniel Malone sold 4,458 shares of the company’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $123.03, for a total value of $548,467.74. Following the sale, the vice president now directly owns 33,478 shares of the company’s stock, valued at $4,118,798.34. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.70% of the stock is owned by corporate insiders.

Shares of WST stock opened at $116.06 on Friday. The firm has a market capitalization of $8.71 billion, a P/E ratio of 41.30, a PEG ratio of 3.61 and a beta of 1.29. West Pharmaceutical Services Inc. has a twelve month low of $90.34 and a twelve month high of $125.09. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.13 and a current ratio of 2.88.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, April 25th. The medical instruments supplier reported $0.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.08. The company had revenue of $443.50 million for the quarter, compared to analysts’ expectations of $431.00 million. West Pharmaceutical Services had a return on equity of 16.38% and a net margin of 12.53%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 earnings per share. As a group, equities analysts anticipate that West Pharmaceutical Services Inc. will post 2.87 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 7th. Investors of record on Wednesday, July 24th will be paid a $0.15 dividend. The ex-dividend date is Tuesday, July 23rd. This represents a $0.60 annualized dividend and a yield of 0.52%. West Pharmaceutical Services’s payout ratio is 21.35%.

TRADEMARK VIOLATION NOTICE: “West Pharmaceutical Services Inc. (WST) Shares Bought by Janney Montgomery Scott LLC” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/24/west-pharmaceutical-services-inc-wst-shares-bought-by-janney-montgomery-scott-llc.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Recommended Story: What are the components of an earnings report?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.